Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis of 3-cyanoindoles using copper catalysis. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN118126005B details metal-free synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN111423381A details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116768904B reveals high-yield chiral synthesis for antitumor intermediates, offering significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN109734662A reveals metal-free trifluoromethylation. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates globally.
Patent CN108610304B details a novel Pd-catalyzed C-H activation route for diaryl sultams, offering superior atom economy and simplified supply chains for pharmaceutical intermediates.
New one-step synthesis route for indole carbazoles reduces costs and improves scalability for pharmaceutical intermediate manufacturing supply chains.
Patent CN118619879A reveals a Rh-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation patent CN114751883B offers efficient synthesis. Reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates.
Novel elemental sulfur-promoted method for high-purity triazole intermediates. Reduces cost and improves supply chain reliability for pharma manufacturing.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Novel iridium catalyzed asymmetric synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates globally.
This report analyzes patent CN103804187B for Jacaronic Acid A synthesis offering scalable production and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel one-pot synthesis of quinone thiazole compounds. Reduces steps, eliminates toxic oxidants. Reliable pharmaceutical intermediate supplier for scale-up.
Novel 4-step enzymatic route for Ritlecitinib Tosylate. Eliminates metal catalysts and chiral columns. High purity, scalable supply for global pharma partners.
Patent CN108610304A reveals a novel Pd-catalyzed route for diarylsultams, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.